Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bba842fc4d37dfcaced1b55bc0c91c7c |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-044 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-044 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-407 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18 |
filingDate |
2012-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15f8cc73a5d5af1e5a2f1ea7c53dd8a6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_937963b39574534b8499d23588e27a2e |
publicationDate |
2014-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-2710009-A1 |
titleOfInvention |
Novel crystalline asenapine hydrochloride salt forms |
abstract |
The invention relates to novel crystalline HCl salts of Asenapine and to methods of their preparation. Furthermore the invention relates to the use of the novel salts in pharmaceutical compositions and the use of the novel salts in the treatment of psychotic diseases or disorders such as schizophrenia and acute mania associated with bipolar disorder. |
priorityDate |
2011-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |